1. Activation of Notch1 promotes development of human CD8+ single positive T cells in humanized mice
- Author
-
Makiko Suzuki, Naoto Ishii, Yoichi Haji, Masamichi Mizuma, Michiaki Unno, Takanori So, Kunihiko Moriya, and Katsuto Hozumi
- Subjects
Carcinogenesis ,T cell ,Biophysics ,CD8-Positive T-Lymphocytes ,Biology ,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma ,Biochemistry ,Mice ,Interleukin 21 ,Mice, Inbred NOD ,hemic and lymphatic diseases ,medicine ,Animals ,Humans ,Cytotoxic T cell ,IL-2 receptor ,Receptor, Notch1 ,Molecular Biology ,Interleukin 3 ,ZAP70 ,Hematopoietic Stem Cell Transplantation ,Cell Biology ,Hematopoietic Stem Cells ,Natural killer T cell ,Molecular biology ,Disease Models, Animal ,medicine.anatomical_structure ,Immunology ,Spleen ,CD8 - Abstract
Notch1 mutations are found in more than 50% of human T cell acute lymphoblastic leukemia (T-ALL) cells. However, the functions of Notch1 for human T cell development and leukemogenesis are not well understood. To examine the role of Notch1, human hematopoietic stem cells (HSCs), which had been transduced with a constitutively active form of Notch1 (ICN1), were transplanted into severely immunodeficient NOD/Shi-scid-IL2rγ(null) (NOG) mice. We found that the great majority of the ICN1-expressing hematopoietic cells in the bone marrow expressed surface markers for T cells, such as CD3, CD4, and CD8, and that this T cell development was independent of the thymus. Accordingly, phenotypically mature CD8(+) single positive (SP) T cells were observed in the spleen. Furthermore, T-ALL developed in one NOG recipient mouse out of 26 that had been secondary transferred with the T cells developed in the first NOG mice. These results indicate that Notch1 signaling in HSCs promotes CD8(+) SP T cell development, and that T cell leukemogenesis may require additional oncogenic factors other than Notch1 activation.
- Published
- 2014
- Full Text
- View/download PDF